Prolonged Remission in Multiple Relapsed MLL-rearranged Infant
B-ALL with Inotuzumab Ozogamicin
Akhila Lattupally MD1, Adonis Lorenzana
MD1, Gregory Anthony Yanik MD2,
Danielle Bell MD1,3
1. Ascension St. John Children’s
Hospital, Detroit, Michigan, United States.
2. C.S. Mott Children’s Hospital – University of Michigan, Ann Arbor,
Michigan, United States.
3. Children’s Hospital of Michigan, Detroit, Michigan, United States.
Corresponding Author: Akhila Lattupally MD
Address: 22101 Moross Rd, PB2, Suite 70, Detroit, Michigan 48236
Phone: 469-468-7978
Fax: 313-343-4756
Email:Akhila.Lattupally@ascension.org
Word Count: Main text: 841 words
Number of Tables: 0
Number of Figures: 0
Number of Supporting Information Files: 0
Running Title: Remission in Infant ALL with Inotuzumab Ozogamicin.
Keywords: Infant Leukemia, ALL Relapse, Immunotherapy